交易 BeOne Medicines Ltd - ONC
BeOne Medicines Ltd (NASDAQ: ONC) is transforming cancer care by developing next-generation therapies for hematology and solid tumors, with a vision to deliver innovative treatments faster, more equitably and at a lower cost worldwide. Its shares move on clinical-trial read-outs, regulatory milestones, licensing deals and pipeline advancemen -- typical of a high-growth biotech powered by breakthrough potential.最新股票文章

SpaceX上市首日收涨19%——IPO后如何交易SpaceX SPCX差价合约
SpaceX(SPCX)于2026年6月12日在纳斯达克首次上市,开盘报150美元,收盘报160.95美元,较135美元的IPO发行价上涨19.2%。
08:41, 16 六月 2026


